Reuters logo
BRIEF-Dermira presents new data showing impact of primary axillary hyperhidrosis on patients
September 13, 2017 / 12:28 PM / a month ago

BRIEF-Dermira presents new data showing impact of primary axillary hyperhidrosis on patients

Sept 13 (Reuters) - Dermira Inc

* Dermira -‍ presented new patient-reported outcomes data from two Phase 3 clinical trials showing impact of primary axillary hyperhidrosis on patients​

* Dermira - Data suggest if approved, glycopyrronium tosylate wipes to have potential to reduce burden of disease for those with excessive underarm sweating​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below